Cargando…

Clinical implications of serum thrombomodulin in PR3-ANCA-associated vasculitis

BACKGROUND: Vascular injury is the main mechanism in pathophysiology of PR3-ANCA-associated vasculitis. Soluble serum thrombomodulin (sTM) is a membrane-bound receptor for thrombin expressed by vascular endothelial cells. OBJECTIVE: The aim of study was to determine the blood levels of sTM in patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zycinska, K, Wardyn, KA, Zielonka, TM, Krupa, R, Lukas, W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521377/ https://www.ncbi.nlm.nih.gov/pubmed/20156770 http://dx.doi.org/10.1186/2047-783X-14-S4-268

Ejemplares similares

Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement
por: Zycinska, K, et al.
Publicado: (2009)

Rhinologic and sinonasal changes in PR3 ANCA pulmonary vasculitis
por: Zycinska, K, et al.
Publicado: (2010)

PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
por: van Dam, Laura S, et al.
Publicado: (2020)

Acute PR3-ANCA vasculitis in an asymptomatic COVID-19 teenager
por: Wintler, Taylor, et al.
Publicado: (2021)

Membrane expression of neutrophil proteinase 3 (PR3) is associated with relapse in PR3-ANCA related vasculitis
por: Rarok, AA, et al.
Publicado: (2002)

Infection is associated with increased risk of MPO- but not PR3-ANCA-associated vasculitis
por: Rathmann, Jens, et al.
Publicado: (2022)

Chemokine/Cytokine Levels Correlate with Organ Involvement in PR3-ANCA-Associated Vasculitis
por: Müller-Deile, Janina, et al.
Publicado: (2021)

Reactivity against Complementary Proteinase-3 Is Not Increased in Patients with PR3-ANCA-Associated Vasculitis
por: Tadema, Henko, et al.
Publicado: (2011)

Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise
por: Wojcik, Iwona, et al.
Publicado: (2023)

Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function
por: Zielonka, TM, et al.
Publicado: (2010)

Angiogenic activity of sera from interstitial lung disease patients in relation to clinical and radiological changes
por: Zielonka, TM, et al.
Publicado: (2009)

Diagnosing ANCA-associated vasculitis in ANCA positive patients: A retrospective analysis on the role of clinical symptoms and the ANCA titre
por: Houben, Eline, et al.
Publicado: (2016)

ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020)

Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis
por: Kemna, Michael J., et al.
Publicado: (2017)

Interference of PR3-ANCA with the enzymatic activity of PR3
por: Rarok, AA, et al.
Publicado: (2002)

Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management
por: Ge, Shangqing, et al.
Publicado: (2022)

What you should know about PR3-ANCA: Evidence for the role of T cells in the pathogenesis of systemic vasculitis
por: Clayton, Abigail R, et al.
Publicado: (2000)

Is serum HMGB1 a biomarker in ANCA-associated vasculitis?
por: de Souza, Alexandre Wagner Silva, et al.
Publicado: (2013)

What you should know about PR3-ANCA: Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCA
por: Specks, Ulrich
Publicado: (2000)

FIBROTIC PROTEASE 3 ANCA-ASSOCIATED VASCULITIS
por: Megri, Mohammed, et al.
Publicado: (2020)

The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)

Immunopathogenesis of ANCA-Associated Vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-associated vasculitis of the appendix
por: Leaver, Phillip J, et al.
Publicado: (2019)

Comorbidities in ANCA-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-Associated Vasculitis: An Update
por: Almaani, Salem, et al.
Publicado: (2021)

PR3-ANCA-positive Pulmonary Cryptococcosis
por: Goto, Akihiko, et al.
Publicado: (2017)

Rituximab used for simultaneous treatment of PR3‐ANCA positive vasculitis associated with rheumatoid arthritis: A case report
por: Yamada, Akihiro, et al.
Publicado: (2020)

Leukocytoclastic Vasculitis as a Rare Dermatologic Extraintestinal Manifestation of Ulcerative Colitis in an Elderly Patient with Positive PR3-ANCA
por: Ng, Jacky, et al.
Publicado: (2021)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019)

COVID-19 vaccination precipitating de novo ANCA-associated vasculitis: clinical implications
por: Mai, Aaron Shengting, et al.
Publicado: (2022)

PR3ANCA Related Cerebral Vasculitis in Ulcerative Colitis Presenting with Orbital Involvement: A Case Report with Review of Literature
por: Unnikrishnan, Athira, et al.
Publicado: (2014)

A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol
por: McClure, Mark E., et al.
Publicado: (2023)

Progress in treatment of ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2012)

Animal Models of ANCA Associated Vasculitis
por: Shochet, Lani, et al.
Publicado: (2020)

Eye involvement in ANCA positive vasculitis
por: Macarie, Sorin Simion, et al.
Publicado: (2020)

Mechanisms of thrombosis in ANCA-associated vasculitis
por: Misra, Durga Prasanna, et al.
Publicado: (2021)

Granulomatous Inflammation in ANCA-Associated Vasculitis
por: Müller, Antje, et al.
Publicado: (2021)

Complement Inhibition in ANCA-Associated Vasculitis
por: Tesar, Vladimir, et al.
Publicado: (2022)

The involvement of NETs in ANCA-associated vasculitis
por: Shiratori-Aso, Satoka, et al.
Publicado: (2023)

Different Types of ANCA Determine Different Clinical Phenotypes and Outcome in ANCA-Associated Vasculitis (AAV)
por: Bantis, Kostas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v4blp0i5v9jqfgrdc959dndr28